DLB vs XPER: Which Is the Better Buy in 2026?
Last updated September 2026
Short answer
DLB is the larger of the two ($5.75B market cap): the incumbent the market prices for continued execution (13.36x forward earnings, beta 0.80). XPER is the smaller challenger ($282.88M), cheaper on forward earnings (4.32x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
DLB vs XPER: the tie-breaker metrics
Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | DLB | XPER | What it tells you |
|---|---|---|---|
| Market cap | $5.75B | $282.88M | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.36 | 4.32 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 0.80 | 0.92 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 52% of range | 20% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.23 | 0.68 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: XPER is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how DLB and XPER affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DLB and XPER share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DLB and XPER exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Dolby Laboratories (DLB) do?
Dolby Laboratories licenses audio and imaging technologies to device makers, content creators, and distributors, earning royalties each time its formats are embedded in hardware or content. Its flagship brands (Dolby Atmos for immersive audio and Dolby Vision for HDR imaging) sit inside televisions, smartphones, PCs, set-top boxes, sound systems, streaming platforms, cinemas, and increasingly automotive infotainment. The model is asset-light: Dolby invests heavily in R&D and standardization, then monetizes the resulting patents and trademarks at very high gross margins once a format reaches critical mass.
What does Xperi Inc. (XPER) do?
Xperi Inc. is a consumer and entertainment technology company spun off from Xperi Holding Corporation (now Adeia Inc., the IP licensing business) in October 2022. The company provides technology platforms primarily for connected TV and entertainment, automotive infotainment, and various consumer electronics applications. The largest product line is the TiVo platform, including TiVo OS (the smart TV operating system used by TV manufacturers and pay-TV operators), TiVo metadata, and TiVo personalized content discovery.
DLB vs XPER: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- DLB drivers: Atmos and Vision penetration; Automotive as a new surface.
- XPER drivers: TiVo OS adoption by TV manufacturers; Pay-TV operator transitions.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Dolby's revenue is concentrated in patent and technology licensing, so expiring patents and the need to keep introducing successful new formats are structural risks to long-term royalty streams. For XPER, tiVo OS adoption pace is uncertain; competition from Google TV and Roku is intense.
DLB or XPER: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick DLB if you believe its drivers more; XPER if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DLB and XPER guides.
DLB vs XPER: the full fundamentals
DLB. Dolby trades at a mid-20s trailing earnings multiple that falls to the mid-teens on forward estimates, reflecting expected fiscal 2026 EPS growth toward the ~$2.66-$2.81 GAAP range. The valuation embeds a steady, high-margin licensing franchise with a strong net-cash balance sheet rather than a rapid grower. The gap between trailing and forward multiples partly reflects licensing true-ups and cyclicality that make single-year comparisons uneven.
XPER. Xperi's valuation analysis is more about path-to-profitability and TiVo OS adoption than current earnings. Price-to-sales is modest reflecting the execution risk and the structural pressure on the pay-TV legacy business. Successful TiVo OS scaling would meaningfully change the financial profile.
Headline figures (approximate, July 2026): DLB shows revenue (fy2025) ~$1.35B, net income (fy2025) ~$255M, fy2026 revenue guidance ~$1.4B-$1.45B, market cap ~$5.9B; XPER shows revenue (ttm) ~$500 million, operating margin Modest non-GAAP positive; GAAP near breakeven, net income (ttm) GAAP near breakeven; modest non-GAAP profit, eps (ttm) Near zero (GAAP).
The bottom line: DLB vs XPER
DLB and XPER are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined DLB and XPER exposure against your real portfolio. It is not an investment adviser.
Wondering how DLB or XPER fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Dolby Laboratories with AI
Connect the broker you already use and ask Walnut's AI how DLB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between DLB and XPER?
+
Dolby Laboratories licenses audio and imaging technologies to device makers, content creators, and distributors, earning royalties each time its formats are embedded in hardware or content. Xperi Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is DLB or XPER the better stock?
+
Neither is universally better. DLB is the larger incumbent; XPER is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, DLB or XPER?
+
On forward P/E (as of September 2026), DLB trades at 13.36x and XPER at 4.32x, so XPER is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both DLB and XPER?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of DLB vs XPER?
+
DLB: Dolby's revenue is concentrated in patent and technology licensing, so expiring patents and the need to keep introducing successful new formats are structural risks to long-term royalty streams. Results are exposed to consumer-electronics cyclicality and are lumpy because of periodic licensing true-ups and catch-up payments, which can swing quarterly comparisons meaningfully. A slowdown in TV, smartphone, or PC unit shipments would directly pressure royalties, and license renewals with major device makers can reset economics. Competition from Xperi/DTS, Sony, and other audio and imaging IP holders, plus the risk that a customer favors royalty-free or in-house alternatives, could erode share over time. Growth is modest, so multiple compression is a risk if the market expects more than mid-single-digit expansion. XPER: TiVo OS adoption pace is uncertain; competition from Google TV and Roku is intense. Pay-TV decline pressures part of the legacy business. Smaller capitalization with limited institutional float.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DLB or XPER; figures are approximate and dated (as of September 2026). Verify current data before investing.